Bg pattern

CLOPERASTINE NORMON 3.54 mg/ml ORAL SUSPENSION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CLOPERASTINE NORMON 3.54 mg/ml ORAL SUSPENSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Cloperastina Normon 3.54 mg/ml Oral Suspension

cloperastine fendizoate

Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you

Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist exactly.

  • Keep this package leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in the package leaflet.
  • You should consult your doctor if your condition worsens or does not improve after 7 days.

Contents of the Package Leaflet:

  1. What is Cloperastina Normon and what is it used for
  2. What you need to know before taking Cloperastina Normon
  3. How to take Cloperastina Normon
  4. Possible side effects
  5. Storage of Cloperastina Normon
  6. Package Contents and Additional Information
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

1. What is Cloperastina Normon and what is it used for

The active ingredient of this medication, cloperastine, is an antitussive that inhibits the cough reflex.

Cloperastina Normon is a medication indicated for the treatment of non-productive forms of cough, such as irritative or nervous cough in adults and children from 2 years of age.

You should consult a doctor if your condition worsens or does not improve after 7 days of treatment.

2. What you need to know before taking Cloperastina Normon

Do not take Cloperastina Normon if

  • You are allergic (hypersensitive) to the active ingredient or any of the other components of Cloperastina Normon.
  • You are allergic to allergy medications (antihistamines).
  • You are taking medications for the treatment of depression.
  • You are pregnant or think you may be pregnant or are breastfeeding.
  • Children under 2 years of age cannot take this medication.

Warnings and Precautions

Consult your doctor or pharmacist before starting to take Cloperastina Normon:

  • If you have high intraocular pressure.
  • If you have been told you have prostate hypertrophy.
  • If the cough persists after 7 days of treatment.

Children

Children under 2 years of age cannot take this medication; it is contraindicated.

Taking Cloperastina Normon with other medications

Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

Cloperastina Normon may interact with other medications such as:

  • Medications to help you sleep (sedatives, opioid analgesics, barbiturates, hypnotics, or benzodiazepines).
  • Medications for depression and medications for the treatment of Parkinson's disease, as they may potentiate the adverse effects of this medication.
  • Expectorant and mucolytic medications used to eliminate excess mucus and phlegm, as taking them at the same time as a cough medication like Cloperastina Normon may prevent the elimination of excess mucus and produce choking.

Taking Cloperastina Normon with food, drinks, and alcohol

During treatment with Cloperastina Normon, do not consume alcohol, as it may increase the effects of alcohol.

Taking this medication with food and drinks does not affect its efficacy.

Pregnancy and Breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

It is contraindicated in pregnancy and breastfeeding.

Driving and Using Machines

Cloperastina Normon may cause drowsiness at usual doses. If so, refrain from driving and operating hazardous machinery.

Cloperastina Normon contains propyl parahydroxybenzoate, methyl parahydroxybenzoate, and sodium

It may cause allergic reactions (possibly delayed) and, exceptionally, bronchospasm, as it contains propyl parahydroxybenzoate (E-216) and methyl parahydroxybenzoate (E-218).

This medication contains less than 1 mmol of sodium (23 mg) per ml; it is essentially "sodium-free".

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to take Cloperastina Normon

Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist exactly. In case of doubt, ask your doctor or pharmacist.

The recommended dose is:

For adults and children over 12 years old: 10 ml, 3 times a day

For children:

Between 7 and 12 years old: 5 ml, 2 times a day.

Between 5 and 6 years old: 3 ml, 2 times a day.

Between 2 and 4 years old: 2 ml, 2 times a day.

Cloperastina Normon is contraindicated in children under 2 years of age.

How to take

Shake the bottle before use.

This medication is taken orally.

Measure the amount of medication to be taken with the 5 ml graduated syringe with marks at 1 ml, 2 ml, 3 ml, 4 ml, and 5 ml and intermediate marks every 0.5 ml, included in the box.

If you take more Cloperastina Normon than you should

The symptoms of overdose are: excitement and difficulty breathing.

If you have taken more Cloperastina Normon than you should, consult your doctor or pharmacist immediately or call the toxicology information service at 91 562 04 20, indicating the medication and the amount taken.

4. Possible side effects

Like all medications, Cloperastina Normon can cause side effects, although not everyone experiences them.

The most common ones are: drowsiness and dry mouth.

Side effects that may occur are:

Uncommon: may affect up to 1 in 100 patients: drowsiness, dry mouth (at high doses).

Very rare: may affect up to 1 in 10,000 patients: allergic reaction, urticaria.

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Cloperastina Normon

This medication does not require special storage conditions.

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.

6. Package Contents and Additional Information

Composition of Cloperastina Normon

The active ingredient is cloperastine (as fendizoate). Each ml contains 3.54 mg of cloperastine fendizoate (equivalent to 2 mg of cloperastine hydrochloride).

The other components are: methyl parahydroxybenzoate (E-218), propyl parahydroxybenzoate (E-216), xanthan gum (E-415), glycerin (E-422), Carbopol 974P, macrogol 40 stearate, sodium saccharin (E-954), banana flavor, and purified water.

Appearance of the Product and Package Contents

It is presented as an oral suspension. Each package contains 120 ml or 200 ml of oral suspension and a 5 ml graduated syringe with marks at 1 ml, 2 ml, 3 ml, 4 ml, and 5 ml and intermediate marks every 0.5 ml.

Marketing Authorization Holder and Manufacturer

LABORATORIOS NORMON, S.A.

Ronda de Valdecarrizo, 6 - 28760 Tres Cantos - Madrid (SPAIN)

Date of the Last Revision of this Package Leaflet:

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.

Online doctors for CLOPERASTINE NORMON 3.54 mg/ml ORAL SUSPENSION

Discuss questions about CLOPERASTINE NORMON 3.54 mg/ml ORAL SUSPENSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for CLOPERASTINE NORMON 3.54 mg/ml ORAL SUSPENSION?
CLOPERASTINE NORMON 3.54 mg/ml ORAL SUSPENSION does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in CLOPERASTINE NORMON 3.54 mg/ml ORAL SUSPENSION?
The active ingredient in CLOPERASTINE NORMON 3.54 mg/ml ORAL SUSPENSION is cloperastine. This information helps identify medicines with the same composition but different brand names.
Who manufactures CLOPERASTINE NORMON 3.54 mg/ml ORAL SUSPENSION?
CLOPERASTINE NORMON 3.54 mg/ml ORAL SUSPENSION is manufactured by Laboratorios Normon S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of CLOPERASTINE NORMON 3.54 mg/ml ORAL SUSPENSION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CLOPERASTINE NORMON 3.54 mg/ml ORAL SUSPENSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to CLOPERASTINE NORMON 3.54 mg/ml ORAL SUSPENSION?
Other medicines with the same active substance (cloperastine) include CINFATUSINA 3.54 mg/ml ORAL SUSPENSION, CLOPERASTINE KERN PHARMA 3.54 mg/ml SYRUP, FLUTOX 10 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media